14.2 Obstructive Sleep Apnea Studies in Adults with Obesity Overview of Study 5 and Study 6 The efficacy of ZEPBOUND for moderate to severe obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI] 15) in patients with obesity (BMI 30 kg/m2) was evaluated in a master protocol clinical trial (NCT05412004) that included two randomized, double-blind, placebo-controlled trials (Study 5 and Study 6) of 52 weeks duration
Gene-specific hypermethylation of 25-hydroxylase, 1--hydroxylase, and VDR, and hypomethylation of CYP24A1 was observed in HFD-fed mice
Yes, telehealth consultations are legitimate and legal when conducted by providers licensed in your state, following proper medical evaluation standards, and complying with state and federal regulations
Others find that night time helps prevent nausea during the day
IET Nanobiotechnol
Comparative effects of liraglutide 3 mg versus structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial